Literature DB >> 2767078

Kinetics of Tc-99m hexakis t-butyl isonitrile in normal and ischemic canine myocardium.

S J Williams1, D L Dragotakos, R D Okada.   

Abstract

Hexakis 99mTc-tertiary butyl isonitrile (99mTc-TBI) was studied as a cardiac perfusion imaging agent in nine dogs with partial occlusion of the LAD. Thirty min after applying the stenosis, 99mTc-TBI was injected into the right atrium (RA) in five dogs and left atrium (LA) in four dogs. Normal and ischemic zone regional myocardial 99mTc-TBI activities were monitored continuously for 4 h. Dogs with LA injections had minimal and equivalent 4 h fractional clearance from the normal and ischemic zones. Dogs with RA injections had minimal, but significantly lower 4 h fractional 99mTc clearances in the ischemic zone (0.08 +/- 0.08) compared to the normal zone (0.16 +/- 0.07, P less than 0.05). The delayed ischemic zone clearance is probably due to the high initial lung uptake observed after RA injection. Despite the differences in clearance, this minimal amount of redistribution could not be detected on gamma camera images. The minimal myocardial washout and redistribution, and the 140 keV gamma make 99mTc-TBI a promising cardiac perfusion imaging agent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767078     DOI: 10.1007/BF00435467

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrile.

Authors:  B L Holman; C A Campbell; J Lister-James; A G Jones; A Davison; R A Kloner
Journal:  J Nucl Med       Date:  1986-07       Impact factor: 10.057

2.  Mechanisms and time course for the disappearance of thallium-201 defects at rest in dogs. Relation of time to peak activity to myocardial blood flow.

Authors:  R D Okada; J A Leppo; H W Strauss; C A Boucher; G M Pohost
Journal:  Am J Cardiol       Date:  1982-03       Impact factor: 2.778

3.  Thallium-201 kinetics in nonischemic canine myocardium.

Authors:  R D Okada; M L Jacobs; W M Daggett; J Leppo; H W Strauss; J B Newell; R Moore; C A Boucher; D O'Keefe; G M Pohost
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

4.  A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.

Authors:  B L Holman; A G Jones; J Lister-James; A Davison; M J Abrams; J M Kirshenbaum; S S Tumeh; R J English
Journal:  J Nucl Med       Date:  1984-12       Impact factor: 10.057

5.  Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents.

Authors:  P Gerundini; A Savi; M C Gilardi; A Margonato; G Vicedomini; L Zecca; W Hirth; K Libson; J C Bhatia; F Fazio
Journal:  J Nucl Med       Date:  1986-03       Impact factor: 10.057

  5 in total
  1 in total

1.  Comparison of stress-only vs. stress/rest with technetium-99m methoxyisobutylisonitrile myocardial perfusion imaging.

Authors:  D F Worsley; A Y Fung; D B Coupland; C G Rexworthy; G P Sexsmith; B C Lentle
Journal:  Eur J Nucl Med       Date:  1992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.